
Immunoprotein Diagnostic Testing Market by Technology (Enzyme-Linked Immunoassay, Immunofluorescence Assay, Radioimmunoassay), Immunoprotein Type (C-reactive Protein, Complement System Protein, Immunoglobulin), Application, End-User - Global Forecast 2024
Description
Immunoprotein Diagnostic Testing Market by Technology (Enzyme-Linked Immunoassay, Immunofluorescence Assay, Radioimmunoassay), Immunoprotein Type (C-reactive Protein, Complement System Protein, Immunoglobulin), Application, End-User - Global Forecast 2024-2030
The Immunoprotein Diagnostic Testing Market size was estimated at USD 8.81 billion in 2023 and expected to reach USD 9.41 billion in 2024, at a CAGR 6.92% to reach USD 14.07 billion by 2030.
Global Immunoprotein Diagnostic Testing Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Immunoprotein Diagnostic Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immunoprotein Diagnostic Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Immunoprotein Diagnostic Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Beckman Coulter Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, BioMérieux S.A., Calbiotech, Inc., Danaher Corporation, DiaSorin S.p.A., DiaSys Diagnostic Systems GmbH, Diazyme Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, Grifols, S.A., Luminex Corporation, Miraca Holdings Inc., Ortho Clinical Diagnostics, QIAGEN N.V., Randox Laboratories Ltd., SERVA Electrophoresis GmbH, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc., and Werfen.
Market Segmentation & Coverage
This research report categorizes the Immunoprotein Diagnostic Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
Technology
Enzyme-Linked Immunoassay
Immunofluorescence Assay
Radioimmunoassay
Immunoprotein Type
C-reactive Protein
Complement System Protein
Immunoglobulin
Application
Allergy Testing
Autoimmune Disease Testing
Endocrine Testing
Infectious Disease Testing
Oncology Testing
Toxicology Testing
End-User
Diagnostic Laboratories
Hospitals & Clinics
Research Institutes
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Immunoprotein Diagnostic Testing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immunoprotein Diagnostic Testing Market?
3. What are the technology trends and regulatory frameworks in the Immunoprotein Diagnostic Testing Market?
4. What is the market share of the leading vendors in the Immunoprotein Diagnostic Testing Market?
5. Which modes and strategic moves are suitable for entering the Immunoprotein Diagnostic Testing Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
185 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Immunoprotein Diagnostic Testing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increase in incidence and prevalence of infectious and chronic diseases
- 5.1.1.2. Growth in demand for early diagnostic services in emerging economies
- 5.1.1.3. Rise in diagnostic tests and growing demand for chemiluminescence assay
- 5.1.2. Restraints
- 5.1.2.1. High cost of immunoprotein diagnostic tests
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements in immunodiagnostic instruments and the introduction of novel automated systems
- 5.1.3.2. Ongoing development in the condition-specific assays and tests
- 5.1.4. Challenges
- 5.1.4.1. Complex regulatory framework for the approval of immunoprotein diagnostic tests
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Immunoprotein Diagnostic Testing Market, by Technology
- 6.1. Introduction
- 6.2. Enzyme-Linked Immunoassay
- 6.3. Immunofluorescence Assay
- 6.4. Radioimmunoassay
- 7. Immunoprotein Diagnostic Testing Market, by Immunoprotein Type
- 7.1. Introduction
- 7.2. C-reactive Protein
- 7.3. Complement System Protein
- 7.4. Immunoglobulin
- 8. Immunoprotein Diagnostic Testing Market, by Application
- 8.1. Introduction
- 8.2. Allergy Testing
- 8.3. Autoimmune Disease Testing
- 8.4. Endocrine Testing
- 8.5. Infectious Disease Testing
- 8.6. Oncology Testing
- 8.7. Toxicology Testing
- 9. Immunoprotein Diagnostic Testing Market, by End-User
- 9.1. Introduction
- 9.2. Diagnostic Laboratories
- 9.3. Hospitals & Clinics
- 9.4. Research Institutes
- 10. Americas Immunoprotein Diagnostic Testing Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Immunoprotein Diagnostic Testing Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.
- 10. South Korea
- 11.
- 11. Taiwan
- 11.
- 12. Thailand
- 11.
- 13. Vietnam
- 12. Europe, Middle East & Africa Immunoprotein Diagnostic Testing Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.
- 10. Nigeria
- 12.
- 11. Norway
- 12.
- 12. Poland
- 12.
- 13. Qatar
- 12.
- 14. Russia
- 12.
- 15. Saudi Arabia
- 12.
- 16. South Africa
- 12.
- 17. Spain
- 12.
- 18. Sweden
- 12.
- 19. Switzerland
- 12.
- 20. Turkey
- 12.
- 21. United Arab Emirates
- 12.
- 22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Abbott Laboratories
- 14.1.2. Abcam PLC
- 14.1.3. Beckman Coulter Inc.
- 14.1.4. Becton, Dickinson and Company
- 14.1.5. Bio-Rad Laboratories Inc.
- 14.1.6. Bio-Techne Corporation
- 14.1.7. BioMérieux S.A.
- 14.1.8. Calbiotech, Inc.
- 14.1.9. Danaher Corporation
- 14.1.
- 10. DiaSorin S.p.A.
- 14.1.
- 11. DiaSys Diagnostic Systems GmbH
- 14.1.
- 12. Diazyme Laboratories Inc.
- 14.1.
- 13. Enzo Biochem Inc.
- 14.1.
- 14. F. Hoffmann-La Roche AG
- 14.1.
- 15. Grifols, S.A.
- 14.1.
- 16. Luminex Corporation
- 14.1.
- 17. Miraca Holdings Inc.
- 14.1.
- 18. Ortho Clinical Diagnostics
- 14.1.
- 19. QIAGEN N.V.
- 14.1.
- 20. Randox Laboratories Ltd.
- 14.1.
- 21. SERVA Electrophoresis GmbH
- 14.1.
- 22. Siemens Healthineers
- 14.1.
- 23. Sysmex Corporation
- 14.1.
- 24. Thermo Fisher Scientific Inc.
- 14.1.
- 25. Werfen
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET RESEARCH PROCESS
- FIGURE 2. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2023 VS 2030
- FIGURE 3. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET DYNAMICS
- FIGURE 7. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 8. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2023 VS 2030 (%)
- FIGURE 10. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 12. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 14. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.